BRIEF-Infinity Pharmaceuticals Announces Termination Of Merger Agreement With MEI Pharma

Reuters

Jul 24, 2023

July 24 (Reuters) - Infinity Pharmaceuticals Inc

:

* INFINITY PHARMACEUTICALS ANNOUNCES TERMINATION OF MERGER AGREEMENT WITH MEI PHARMA

* INFINITY PHARMACEUTICALS INC- EGANELISIB REMAINS PRIMARY VALUE DRIVER FOR INFINITY

* INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS

* INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS

* INFINITY PHARMACEUTICALS INC- INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS

* INFINITY PHARMACEUTICALS - COMPANY'S BOARD AND MANAGEMENT TEAM EXPECT TO UNDERTAKE A SERIES OF COST SAVING MEASURES

* INFINITY PHARMACEUTICALS INC- AS A RESULT OF TERMINATION OF MERGER AGREEMENT, INFINITY ENTITLED TO REIMBURSEMENT OF OF $1 MILLION FROM MEI

* INFINITY PHARMACEUTICALS INC - INFINITY HAS POTENTIAL TO RECEIVE AN ADDITIONAL $4 MILLION TERMINATION FEE FROM MEI UNDER CERTAIN CIRCUMSTANCES

* INFINITY PHARMACEUTICALS INC- COMPANY'S BOARD AND MANAGEMENT TEAM EXPECT TO UNDERTAKE A SERIES OF COST SAVING MEASURES

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2353389870"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2353389870\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2353389870?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-07-24 21:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2353389870","market":"us","top_or_hot":-1,"title":"BRIEF-Infinity Pharmaceuticals Announces Termination Of Merger Agreement With MEI Pharma","media":"Reuters","content":"<html><body><p>July 24 (Reuters) - <a href=\"https://laohu8.com/S/INFI\">Infinity Pharmaceuticals</a> Inc</p><p> :</p><p>   * INFINITY PHARMACEUTICALS ANNOUNCES TERMINATION OF MERGER AGREEMENT WITH MEI PHARMA</p><p>   * INFINITY PHARMACEUTICALS INC- EGANELISIB REMAINS PRIMARY VALUE DRIVER FOR INFINITY</p><p>   * INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS</p><p>   * INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS</p><p>   * INFINITY PHARMACEUTICALS INC- INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS</p><p>   * INFINITY PHARMACEUTICALS - COMPANY'S BOARD AND MANAGEMENT TEAM EXPECT TO UNDERTAKE A SERIES OF COST SAVING MEASURES</p><p>   * INFINITY PHARMACEUTICALS INC- AS A RESULT OF TERMINATION OF MERGER AGREEMENT, INFINITY ENTITLED TO REIMBURSEMENT OF OF $1 MILLION FROM MEI</p><p>   * INFINITY PHARMACEUTICALS INC - INFINITY HAS POTENTIAL TO RECEIVE AN ADDITIONAL $4 MILLION TERMINATION FEE FROM MEI UNDER CERTAIN CIRCUMSTANCES</p><p>   * INFINITY PHARMACEUTICALS INC- COMPANY'S BOARD AND MANAGEMENT TEAM EXPECT TO UNDERTAKE A SERIES OF COST SAVING MEASURES</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Infinity Pharmaceuticals Announces Termination Of Merger Agreement With MEI Pharma</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Infinity Pharmaceuticals Announces Termination Of Merger Agreement With MEI Pharma\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2023-07-24 21:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>July 24 (Reuters) - <a href=\"https://laohu8.com/S/INFI\">Infinity Pharmaceuticals</a> Inc</p><p> :</p><p>   * INFINITY PHARMACEUTICALS ANNOUNCES TERMINATION OF MERGER AGREEMENT WITH MEI PHARMA</p><p>   * INFINITY PHARMACEUTICALS INC- EGANELISIB REMAINS PRIMARY VALUE DRIVER FOR INFINITY</p><p>   * INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS</p><p>   * INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS</p><p>   * INFINITY PHARMACEUTICALS INC- INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS</p><p>   * INFINITY PHARMACEUTICALS - COMPANY'S BOARD AND MANAGEMENT TEAM EXPECT TO UNDERTAKE A SERIES OF COST SAVING MEASURES</p><p>   * INFINITY PHARMACEUTICALS INC- AS A RESULT OF TERMINATION OF MERGER AGREEMENT, INFINITY ENTITLED TO REIMBURSEMENT OF OF $1 MILLION FROM MEI</p><p>   * INFINITY PHARMACEUTICALS INC - INFINITY HAS POTENTIAL TO RECEIVE AN ADDITIONAL $4 MILLION TERMINATION FEE FROM MEI UNDER CERTAIN CIRCUMSTANCES</p><p>   * INFINITY PHARMACEUTICALS INC- COMPANY'S BOARD AND MANAGEMENT TEAM EXPECT TO UNDERTAKE A SERIES OF COST SAVING MEASURES</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4145","symbol_name":"电子制造服务","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2353389870","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2353389870","pubTimestamp":1690206191,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"July 24  - Infinity Pharmaceuticals Inc :   * INFINITY PHARMACEUTICALS ANNOUNCES TERMINATION OF MERGER AGREEMENT WITH MEI PHARMA   * INFINITY PHARMACEUTICALS INC- EGANELISIB REMAINS PRIMARY VALUE DRIVER FOR INFINITY   * INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS   * INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS   * INFINITY PHARMACEUTICALS INC- INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS   * INFINITY PHARMACEUTICALS - COMPANY'S BOARD AND MANAGEMENT TEAM EXPECT TO UNDERTAKE A SERIES OF COST SAVING MEASURES   * INFINITY PHARMACEUTICALS INC- AS A RESULT OF TERMINATION OF MERGER AGREEMENT, INFINITY ENTITLED TO REIMBURSEMENT OF OF $1 MILLION FROM MEI   * INFINITY PHARMACEUTICALS INC - INFINITY HAS POTENTIAL TO RECEIVE AN ADDITIONAL $4 MILLION TERMINATION FEE FROM MEI UNDER CERTAIN CIRCUMSTANCES   * INFINITY PHARMACEUTICALS INC- CO","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4145":"电子制造服务","BK4139":"生物科技","MEI":"Methode Electronics Inc"},"translate_title":"简介-无限制药宣布终止与美制药的合并协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MEI":1,"MEIP":1,"INFI":1},"content_text":"July 24 (Reuters) - Infinity Pharmaceuticals Inc :   * INFINITY PHARMACEUTICALS ANNOUNCES TERMINATION OF MERGER AGREEMENT WITH MEI PHARMA   * INFINITY PHARMACEUTICALS INC- EGANELISIB REMAINS PRIMARY VALUE DRIVER FOR INFINITY   * INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS   * INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS   * INFINITY PHARMACEUTICALS INC- INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS   * INFINITY PHARMACEUTICALS - COMPANY'S BOARD AND MANAGEMENT TEAM EXPECT TO UNDERTAKE A SERIES OF COST SAVING MEASURES   * INFINITY PHARMACEUTICALS INC- AS A RESULT OF TERMINATION OF MERGER AGREEMENT, INFINITY ENTITLED TO REIMBURSEMENT OF OF $1 MILLION FROM MEI   * INFINITY PHARMACEUTICALS INC - INFINITY HAS POTENTIAL TO RECEIVE AN ADDITIONAL $4 MILLION TERMINATION FEE FROM MEI UNDER CERTAIN CIRCUMSTANCES   * INFINITY PHARMACEUTICALS INC- COMPANY'S BOARD AND MANAGEMENT TEAM EXPECT TO UNDERTAKE A SERIES OF COST SAVING MEASURESSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}